Best in Biotech 10 Nov 2022 The five hottest biotech startup companies in Brazil Brazil’s developing economy is supporting an emerging biotech startup scene. Catch a glimpse of the biotech companies causing a stir in Brazil. Over the decades, Brazil has grown into an… November 10, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 30 May 2017 In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight …Before its IPO, it attracted big-time investors like Medicxi and Sofinnova Partners, some of the top European biotech investors. The biotech has 3 different candidates at the clinical stage for… May 30, 2017 - 7 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Apr 2017 The Top 12 Biotech Leaders You Should Know in Basel …is now part of the Board of MM Pharma, from the Netherlands. There’s a really interesting mix of founders of young biotechs, VC people, and legacy biotech bigwigs like those… April 18, 2017 - 6 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
Best in Biotech 20 Dec 2023 Wrapping up 2023: A recap of top biotech moments of this year …of some of the key biotech developments that have shaped the biotech industry in 2023. Table of contents Alzheimer’s disease: 2023, a year of hope and promise 2023 marked a… December 20, 2023 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 21 Sep 2022 The 5 hottest biotech companies making waves in Israel …With its thriving biotech startup scene, Israel remains a key region to watch in the global biotech industry. Keep checking back for the latest startups emerging in Israel’s biotech ecosystem!… September 21, 2022 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 3 Oct 2023 Five impactful biotech companies to know in New York …powerhouse, attracting many biotech companies, after a $1 billion public investment in the industry from the City of New York. This initiative, called LifeSci NYC, will invest $450 million to… October 3, 2023 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Dec 2017 Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017 …biotech companies of 2017! After the doozy of 2016 for biotech and pharma, things could only get better this year — and the European industry didn’t disappoint! The first CAR-T… December 5, 2017 - 6 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2022 Acticor Biotech enrolls first U.S. patient in study for people with acute ischemic stroke The first U.S. patient was enrolled in a study evaluating glenzocimab in those with acute ischemic stroke. Acticor Biotech, a clinical stage biotech company, made the announcement today (September 26)…. September 26, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 17 Oct 2025 NLS Days: How do things look for biotech in Sweden? The Nordic Life Science (NLS) Days took place this week, October 13–14, in Gothenburg, Sweden. Labiotech was on site to take the pulse of the Nordic biotech scene, and, more specifically, of… October 17, 2025 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jul 2022 European biotech stock woes continue but recovery hope remains European biotech stocks continue to disappoint, with half of listed biotechs in the region having just 12 months of cash left. However, a recent report from Bryan, Garnier & Co… July 15, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jan 2023 Lifesciences and biotech in 2023 …year—at least financially—in biotech. Do you see those trends continuing? Although we see overall sentiments to invest in biotech turning positive in 2023 after a weaker 2022, the sector is… January 11, 2023 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 20 Mar 2017 Will BMS Take Over a Danish Biotech in a Massive €400M Deal? Galecto Biotech has presented positive data from a Phase II study with its pulmonary fibrosis candidate, giving BMS the option of take over the biotech. In 2014, Denmark’s Galecto Biotech… March 20, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email